#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fms-like tyrosine kinase 3 positive Leukaemia Congenital myopathy Shprintzen-Goldberg syndrome Insulinoma Primary myelofibrosis Hepatoblastoma Hypergammaglobulinaemia benign monoclonal Oropharyngeal squamous cell carcinoma Hypersensitivity pneumonitis Cerebral amyloid angiopathy Barth syndrome Infertility male Palmoplantar pustulosis Immune-mediated renal disorder More trials…

    Learn about Rare Diseases

    Haemophilia – Basic Information Malignant fibrous histiocytoma Mantle cell lymphoma stage IV – Basic Information Mucopolysaccharidosis I – Treatment Thrombotic thrombocytopenic purpura – Diagnostics Ewing’s sarcoma metastatic – Life with Disease Mantle cell lymphoma stage II – Trials in Disease Factor VIII deficiency – Diagnostics Nodal marginal zone B-cell lymphoma – Diagnostics Prader-Willi syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clenbuterol Hydrochloride Cariprazine Hydrochloride Astegolimab Ebastine Jab-21822 Trometamol Ibrutinib Gedatolisib Budesonide Rucaparib JNJ-75276617 LTI-03 Nadunolimab 2-DEOXY-D-GLUCOSE Escitalopram Oxalate Sufentanil Adagrasib 7-Ethyl-10-Hydroxycamptothecin Fluoroestradiol F-18 Imipenem Monohydrate More therapies…

    Learn about Your Condition

    Abdominal pain Vesicoureteric reflux Biliary tract disorder Triple negative breast cancer Pulmonary hypertension Combined immunodeficiency Hypocalcaemia Blood iron increased Procedural headache Procedural haemorrhage Ovarian cancer Anal abscess Procedural hypotension Stargardt's disease Neuroendocrine carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Neoplasm

  • Study on the Safety and Effectiveness of ATTR-01 for Adults with Certain Types of Solid Tumors

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • ATTR-01
    Spain

  • Study of ALE.P02 for Adults with Advanced or Metastatic Squamous Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • ALE.P02
    • Pembrolizumab
    France Italy Spain

  • Study on the Safety and Effects of VERT-002 for Patients with Advanced Solid Tumors, Including Lung Cancer with MET Alterations

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • VERT-002
    Belgium France Germany Italy The Netherlands Spain

  • Study on PET Imaging with Fianlimab and Cemiplimab for Patients with Advanced Solid Tumors, with or without Platinum-Based Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    • Microsatellite instability cancer
    • Cervix carcinoma
    Investigated Drugs:
    • Fianlimab
    • Cemiplimab
    The Netherlands

  • Study on APL-101 for Treating Advanced Solid Tumors and Non-Small Cell Lung Cancer with MET Changes in Patients

    Recruiting

    1 1 1
    Investigated Diseases:
    • Central nervous system neoplasm
    • Neoplasm
    • Non-small cell lung cancer
    Investigated Drugs:
    • Apl-101
    France Hungary Italy Spain

  • Study Comparing ANV419 and High Dose IL2 in Adoptive Cell Therapy for Patients with Melanoma, Non-Small Cell Lung Cancer, and Cervical Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cervix carcinoma
    • Neoplasm
    • Non-small cell lung cancer
    Investigated Drugs:
    • Autologous Tumour-Infiltrating Lymphocytes
    • Fusion Protein Of Il-2 And Humanised Igg1 Monoclonal Antibody Against Il-2
    • Anv600
    Denmark The Netherlands Spain
Previous Page
1 2 3 4 5 6 … 25
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!